Meet the Fellows Video Series
Meet the talented individuals who were awarded clinical and research fellowship funding from the Neuromuscular Disease Network for Canada (NMD4C), Muscular Dystrophy Canada (MDC), and the Canadian Society of Clinical Neurophysiologists (CSCN)!
The NMD4C and MDC are excited to share a new videos series featuring the five incredible fellows: Drs. Emanuela Pannia, Rebecca Robertson, Collin Luk, Marianne Nury and Alasdair Rathbone, recipients of the Neuromuscular Clinical and Research fellowship funding in 2022. Learn more about them as individuals, how they first became involved with NMD research, the people and experiences that have made a significant impact on their career, a piece of advice they would give others considering a career in NMD research, what excites them about their work, how they see their field advancing and ways we can better support patients.
In the second video of the Meet The Fellows video series we hear from Dr. Pannia, Dr. Robertson, Dr. Luk, Dr. Rathbone, and Dr. Nury on the people and experiences that have had a significant impact on their career. They also share their top piece of advice for anyone considering a career in neuromuscular disorder research or care.
Video #1 – Introduction
Video #2 – Who are the people and what are the experiences that have had a significant impact on their career?
Video #3 – What Excites You the Most About Your Work?
Read next...
NMD4C Hosts 3rd Annual Basic Research Summer School at uOttawa!
From June 8 to 10, 2026, we hosted the 3rd annual NMD4C Basic Research Summer School at the University of Ottawa. The program supported 28 neuromuscular research trainees (graduate students and postdoctoral fellows) from across Canada and focused on developing practical skills, strengthening core knowledge in neuromuscular research, and providing opportunities to present and discuss their work. Through a combination of tutorials, lectures, hands-on workshops in cutting-edge wet lab techniques, flash talks, and both structured and informal networking, participants engaged with faculty, exchanged ideas, and built connections across institutions and career stages.
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.